BCAB
Price
$0.85
Change
+$0.02 (+2.41%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
48.57M
105 days until earnings call
Intraday BUY SELL Signals
CTMX
Price
$4.08
Change
+$0.08 (+2.00%)
Updated
Dec 4, 04:59 PM (EDT)
Capitalization
677.74M
90 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BCAB vs CTMX

Header iconBCAB vs CTMX Comparison
Open Charts BCAB vs CTMXBanner chart's image
BioAtla
Price$0.85
Change+$0.02 (+2.41%)
Volume$486
Capitalization48.57M
CytomX Therapeutics
Price$4.08
Change+$0.08 (+2.00%)
Volume$47.69K
Capitalization677.74M
BCAB vs CTMX Comparison Chart in %
BCAB
Daily Signal:
Gain/Loss:
CTMX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BCAB vs. CTMX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCAB is a Hold and CTMX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 05, 2025
Stock price -- (BCAB: $0.83 vs. CTMX: $4.00)
Brand notoriety: BCAB and CTMX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCAB: 50% vs. CTMX: 65%
Market capitalization -- BCAB: $48.57M vs. CTMX: $691.3M
BCAB [@Biotechnology] is valued at $48.57M. CTMX’s [@Biotechnology] market capitalization is $691.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCAB’s FA Score shows that 0 FA rating(s) are green whileCTMX’s FA Score has 2 green FA rating(s).

  • BCAB’s FA Score: 0 green, 5 red.
  • CTMX’s FA Score: 2 green, 3 red.
According to our system of comparison, CTMX is a better buy in the long-term than BCAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCAB’s TA Score shows that 5 TA indicator(s) are bullish while CTMX’s TA Score has 3 bullish TA indicator(s).

  • BCAB’s TA Score: 5 bullish, 5 bearish.
  • CTMX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BCAB is a better buy in the short-term than CTMX.

Price Growth

BCAB (@Biotechnology) experienced а -2.88% price change this week, while CTMX (@Biotechnology) price change was -5.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.21%. For the same industry, the average monthly price growth was +5.86%, and the average quarterly price growth was +56.03%.

Reported Earning Dates

BCAB is expected to report earnings on Mar 19, 2026.

CTMX is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (+1.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CTMX($678M) has a higher market cap than BCAB($48.6M). CTMX YTD gains are higher at: 288.350 vs. BCAB (39.750). CTMX has higher annual earnings (EBITDA): 44.7M vs. BCAB (-63.02M). CTMX has more cash in the bank: 158M vs. BCAB (18.2M). BCAB has less debt than CTMX: BCAB (6.05M) vs CTMX (6.89M). CTMX has higher revenues than BCAB: CTMX (141M) vs BCAB (11M).
BCABCTMXBCAB / CTMX
Capitalization48.6M678M7%
EBITDA-63.02M44.7M-141%
Gain YTD39.750288.35014%
P/E RatioN/A13.33-
Revenue11M141M8%
Total Cash18.2M158M12%
Total Debt6.05M6.89M88%
FUNDAMENTALS RATINGS
CTMX: Fundamental Ratings
CTMX
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
13
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
9
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCABCTMX
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 7 days ago
76%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 28 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
BCAB
Daily Signal:
Gain/Loss:
CTMX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DCZRX31.830.39
+1.24%
Nomura Small Cap Core R6
ETLNX15.660.10
+0.64%
Eventide Large Cap Focus N
AAISX20.330.09
+0.44%
American Beacon International Eq Adv
GRISX32.170.10
+0.31%
Nationwide S&P 500 Index Instl Svc
BKLSX10.48-0.01
-0.10%
BlackRock U.S. Insights Long/Shrt Eq K

BCAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCAB has been loosely correlated with AXON. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BCAB jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCAB
1D Price
Change %
BCAB100%
+6.00%
AXON - BCAB
41%
Loosely correlated
+1.08%
VCYT - BCAB
38%
Loosely correlated
+3.44%
CTMX - BCAB
38%
Loosely correlated
+4.99%
GALT - BCAB
35%
Loosely correlated
+4.40%
KYMR - BCAB
33%
Loosely correlated
+2.68%
More

CTMX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTMX has been loosely correlated with MLEC. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CTMX jumps, then MLEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTMX
1D Price
Change %
CTMX100%
+4.99%
MLEC - CTMX
42%
Loosely correlated
-6.83%
BGMS - CTMX
39%
Loosely correlated
+16.55%
BCAB - CTMX
37%
Loosely correlated
+6.00%
VCYT - CTMX
36%
Loosely correlated
+3.44%
HOWL - CTMX
36%
Loosely correlated
+6.73%
More